Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1919.8000 -43.70 (-2.23%)
NSE Sep 26, 2025 15:31 PM
Volume: 1.1M
 

logo
Lupin Ltd.
12 Jun 2017
1919.80
-2.23%
Angel Broking
For 4QFY2017, Lupin posted results which were much below expectations mainly on OPM and the net profit front. The revenues came in at `4,162cr v/s. `4,338cr, a yoy growth of 1.3%. On the OPM front, the EBDITA margins came in at 16.6% (v/s. 25.7% expected) v/s. 31.2% in 4QFY2016. Thus, the Adj. PAT during the quarter came in at `380.3cr v/..
Lupin Ltd. has an average target of 2326.00 from 8 brokers.
More from Lupin Ltd.
Recommended